scholarly journals Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer

2014 ◽  
Vol 77 (4) ◽  
pp. 695-703 ◽  
Author(s):  
Hiltrud Brauch ◽  
Matthias Schwab
Keyword(s):  
Breast Cancer ◽  
Genetic Variation ◽  
Early Breast Cancer ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer

1998 ◽  
Vol 79 (2) ◽  
pp. 311-315 ◽  
Author(s):  
M Dowsett ◽  
J S Tobias ◽  
A Howell ◽  
G M Blackman ◽  
H Welch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany

Breast Care ◽  
2009 ◽  
Vol 4 (6) ◽  
pp. 389-396 ◽  
Author(s):  
Sebastian Braun ◽  
Thomas Mittendorf ◽  
Thomas Menschik ◽  
Wolfgang Greiner ◽  
Johann-Matthias von der Schulenburg
Keyword(s):  
Breast Cancer ◽  
Cost Effectiveness ◽  
Early Breast Cancer ◽  
Menopausal Women ◽  
Post Menopausal

Upper limb function: Comparison of postmenopause women with and without a history of early breast cancer.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e20578-e20578
Author(s):  
Nasim Foroughi ◽  
Mi-Joung Lee ◽  
Sharon Kilbreath
Keyword(s):  
Breast Cancer ◽  
Cancer Treatment ◽  
Early Breast Cancer ◽  
Upper Limb ◽  
Breast Cancer Treatment ◽  
Community Dwelling ◽  
Control Group ◽  
Menopausal Women ◽  
History Of ◽  
Post Menopausal

e20578 Background: Long term upper limb impairments following early breast cancer treatment are commonly reported in women years following surgery. However, the extent to which the symptoms are related to menopause and ageing, rather than cancer, has not been explored. This study aimed to compare upper limb strength, shoulder forward flexion range of motion (FF RoM), and presence of impairments in post menopausal women with and without a history of breast cancer. Methods: Community–dwelling age and body mass index (BMI)-matched post menopausal women with (n=40) and without a history of early breast cancer treatment (n=40) participated. Women with other types of cancer, metastatic cancer, and significant neurological or musculoskeletal history unrelated to breast cancer were excluded. Peak shoulder muscle strength was assessed using pneumatic resistance machines and FF RoM with a digital inclinometer. Participants completed the Disability of arm, shoulder and hand (DASH) questionnaire. Between groups comparison were made using analysis of co-variance with age and BMI as confounding variables. Results: Upper limb strength (206.22±45.0 vs. 225.36±86.9 Nm/kg, p=0.091) and FF RoM (166.75±7.9◦ vs. 170.14±6.9◦, p=0.259) were not significantly different between the study and the control group. There were no significant differences between the groups on any of the DASH sub scores (pain: 9.18±8.1 vs. 8.62±8.2, P=0.770). Conclusions: Upper limb impairments are often presumed to be a consequence of surgical procedures in women with breast cancer. However, some of the symptoms women perceive years following surgery may be related to the changes due to aging or menopause rather than cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document